VALLOUREC
20.4.2026 12:00:00 CEST | Globenewswire | Press release
Invitation: Q1 2026 Results Release and Conference Call - Wednesday, May 13th, 2026
Invitation: Q1 2026 Results Release and Conference Call - Wednesday, May 13th, 2026
Invitation: Q1 2026 Results Release and Conference Call
Wednesday, May 13th, 2026
Vallourec will publish First Quarter 2026 Results on May 13th, 2026 at 07:30 AM CET.
Philippe Guillemot, Chairman of the Board and Chief Executive Officer, and Nathalie Delbreuve, Chief Financial Officer are pleased to invite you to a presentation of the results via conference call and webcast at 09:30 AM CET.
To connect to the webcast (live and replay), please visit:
https://vallourec.engagestream.euronext.com/2026-05-13-q1analystcall
To participate in the call, please visit:
https://engagestream.euronext.com/vallourec/2026-05-13-q1analystcall/dial-in
The presentation will be available from 09:00 AM CET on Vallourec’s website: https://www.vallourec.com/en/investors
About Vallourec
Vallourec is a world leader in premium tubular solutions for the energy markets and for demanding industrial applications such as oil & gas wells in harsh environments, new generation power plants, challenging architectural projects, and high-performance mechanical equipment. Vallourec’s pioneering spirit and cutting-edge R&D open new technological frontiers. With close to 13,000 dedicated and passionate employees in more than 20 countries, Vallourec works hand-in-hand with its customers to offer more than just tubes: Vallourec delivers innovative, safe, competitive and smart tubular solutions, to make every project possible.
Listed on Euronext in Paris (ISIN code: FR0013506730, Ticker VK), Vallourec is part of the CAC Mid 60, SBF 120 and Next 150 indices and is eligible for Deferred Settlement Service.
In the United States, Vallourec has established a sponsored Level 1 American Depositary Receipt (ADR) program (ISIN code: US92023R4074, Ticker: VLOWY). Parity between ADR and a Vallourec ordinary share has been set at 5:1.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Aktieselskabet Schouw & Co.20.4.2026 15:00:00 CEST | Press release
Schouw & Co. share buy-back programme, week 16 2026
Orion Oyj20.4.2026 15:00:00 CEST | Press release
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
Netcompany Group A/S20.4.2026 14:51:44 CEST | Press release
Transactions in connection with share buyback programme
ALK Abello20.4.2026 14:33:12 CEST | Press release
ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy
ALK Abello20.4.2026 14:33:12 CEST | Pressemeddelelse
ALK annoncerer positive fase 2-resultater for tablet til behandling af peanutallergi, som viser tidligt indsættende effekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom